Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
David O. Watson Insider Profile
4 Followers
David O. Watson, GC at Apellis Pharmaceuticals, holds 187.89K shares in Apellis Pharmaceuticals (Ticker: APLS). Most recently, David O. Watson Sold $4,965 shares of Apellis Pharmaceuticals on Jan 14, 2025 for an estimated value of 142.50K.
Profitable Transactions
7 out of 11 Profitable Transactions
Average Return
+15.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of David O. Watson's holdings
Insider Roles
GC
Roles that David O. Watson holds in companies
Most Profitable Insider Trade
The most profitable trade made by David O. Watson
David O. Watson's Trading History
List of latest transactions for each holding click on a transaction to see David O. Watson's performance on stock
You May Also Like
David O. Watson insider profile FAQ
What is the percentage of profitable transactions made by David O. Watson?
The percentage of profitable transactions made by David O. Watson is 64%.
What is the average return per transaction made by David O. Watson?
The average return per transaction made by David O. Watson is 15.90%.
What stocks does David O. Watson hold?
David O. Watson holds: APLS stocks.
What was David O. Watson’s latest transaction?
David O. Watson latest transaction was an Informative Sell of $142.50K.
What was David O. Watson's most profitable transaction?
David O. Watson’s most profitable transaction was an Informative Sell of APLS stock on January 23, 2024. The return on the trade was 58.50%.
What is David O. Watson's role in Apellis Pharmaceuticals?
David O. Watson's role in Apellis Pharmaceuticals is GC.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.